CTS communications distributed on July 6th and July 20th. In working with Grifols on the availability of ZIKV test reagents, CTS projects that you should be prepared to convert from a ZIKV clinical trial test to a licensed test as early as October 29, 2018. The communication includes a quick survey link and instructions to register for the upcoming webinar.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...